• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药代动力学建模

Modeling Pharmacokinetics.

作者信息

Bois Frederic Y, Brochot Céline

机构信息

INERIS, DRC/VIVA/METO, Parc ALATA, BP 2, 60550, Verneuil en Halatte, France.

出版信息

Methods Mol Biol. 2016;1425:37-62. doi: 10.1007/978-1-4939-3609-0_3.

DOI:10.1007/978-1-4939-3609-0_3
PMID:27311461
Abstract

Pharmacokinetics is the study of the fate of xenobiotics in a living organism. Physiologically based pharmacokinetic (PBPK) models provide realistic descriptions of xenobiotics' absorption, distribution, metabolism, and excretion processes. They model the body as a set of homogeneous compartments representing organs, and their parameters refer to anatomical, physiological, biochemical, and physicochemical entities. They offer a quantitative mechanistic framework to understand and simulate the time-course of the concentration of a substance in various organs and body fluids. These models are well suited for performing extrapolations inherent to toxicology and pharmacology (e.g., between species or doses) and for integrating data obtained from various sources (e.g., in vitro or in vivo experiments, structure-activity models). In this chapter, we describe the practical development and basic use of a PBPK model from model building to model simulations, through implementation with an easily accessible free software.

摘要

药物动力学是研究异生物质在活生物体中的命运。基于生理的药物动力学(PBPK)模型提供了异生物质吸收、分布、代谢和排泄过程的真实描述。它们将身体建模为一组代表器官的均匀隔室,其参数涉及解剖学、生理学、生物化学和物理化学实体。它们提供了一个定量的机制框架,以理解和模拟物质在各种器官和体液中的浓度随时间变化的过程。这些模型非常适合进行毒理学和药理学固有的外推(例如,在物种或剂量之间),以及整合从各种来源获得的数据(例如,体外或体内实验、构效关系模型)。在本章中,我们将通过使用易于获取的免费软件进行实现,描述一个PBPK模型从模型构建到模型模拟的实际开发和基本使用。

相似文献

1
Modeling Pharmacokinetics.药代动力学建模
Methods Mol Biol. 2016;1425:37-62. doi: 10.1007/978-1-4939-3609-0_3.
2
PBPK Modeling to Simulate the Fate of Compounds in Living Organisms.基于生理的药代动力学模型模拟化合物在生物体内的命运。
Methods Mol Biol. 2022;2425:29-56. doi: 10.1007/978-1-0716-1960-5_2.
3
PBPK models in risk assessment--A focus on chloroprene.风险评估中的生理药代动力学(PBPK)模型——以氯丁二烯为重点
Chem Biol Interact. 2007 Mar 20;166(1-3):352-9. doi: 10.1016/j.cbi.2007.01.016. Epub 2007 Feb 8.
4
A stochastic whole-body physiologically based pharmacokinetic model to assess the impact of inter-individual variability on tissue dosimetry over the human lifespan.用于评估个体间变异性对人类寿命期间组织剂量影响的随机全身生理药代动力学模型。
Regul Toxicol Pharmacol. 2010 Jun;57(1):103-16. doi: 10.1016/j.yrtph.2010.01.005. Epub 2010 Feb 1.
5
Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.基于贝叶斯群体生理药代动力学(PBPK)方法对临床相关群体个体间变异性进行生理现实特征描述
PLoS One. 2015 Oct 2;10(10):e0139423. doi: 10.1371/journal.pone.0139423. eCollection 2015.
6
Evaluating parameter availability for physiologically based pharmacokinetic (PBPK) modeling of perfluorooctanoic acid (PFOA) in zebrafish.评估基于生理的药代动力学(PBPK)模型中全氟辛酸(PFOA)在斑马鱼中参数可用性。
Environ Sci Process Impacts. 2018 Jan 24;20(1):105-119. doi: 10.1039/c7em00474e.
7
Resurgence in the use of physiologically based pharmacokinetic models in pediatric clinical pharmacology: parallel shift in incorporating the knowledge of biological elements and increased applicability to drug development and clinical practice.基于生理学的药代动力学模型在儿科临床药理学中的应用复苏:整合生物学要素知识的平行转变以及在药物研发和临床实践中适用性的提高。
Paediatr Anaesth. 2011 Mar;21(3):291-301. doi: 10.1111/j.1460-9592.2010.03323.x.
8
Physiologically-based pharmacokinetic modeling to predict the clinical pharmacokinetics of monoclonal antibodies.基于生理的药代动力学建模以预测单克隆抗体的临床药代动力学。
J Pharmacokinet Pharmacodyn. 2016 Aug;43(4):427-46. doi: 10.1007/s10928-016-9482-0. Epub 2016 Jul 4.
9
Computational toxicology: application in environmental chemicals.计算毒理学:在环境化学物质中的应用
Methods Mol Biol. 2012;929:9-19. doi: 10.1007/978-1-62703-050-2_2.
10
Integration of dissolution into physiologically-based pharmacokinetic models III: PK-Sim®.溶出度整合到基于生理的药代动力学模型中 III:PK-Sim®。
J Pharm Pharmacol. 2012 Jul;64(7):997-1007. doi: 10.1111/j.2042-7158.2012.01534.x. Epub 2012 May 16.

引用本文的文献

1
A Generalized Physiologically Based Kinetic Model for Fish for Environmental Risk Assessment of Pharmaceuticals.用于药物环境风险评估的鱼类广义生理基础动力学模型
Environ Sci Technol. 2022 May 17;56(10):6500-6510. doi: 10.1021/acs.est.1c08068. Epub 2022 Apr 26.
2
Characterizing environmental geographic inequalities using an integrated exposure assessment.利用综合暴露评估刻画环境地理不平等。
Environ Health. 2021 May 12;20(1):58. doi: 10.1186/s12940-021-00736-9.
3
Challenges Associated With Applying Physiologically Based Pharmacokinetic Modeling for Public Health Decision-Making.
应用基于生理学的药代动力学模型进行公共卫生决策面临的挑战。
Toxicol Sci. 2018 Apr 1;162(2):341-348. doi: 10.1093/toxsci/kfy010.